line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,MOREPENLAB.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.239147,MOREPENLAB.NS
Normalized EBITDA,2025-03-31 00:00:00,1924340000.0,MOREPENLAB.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,1180204000.0,MOREPENLAB.NS
Reconciled Depreciation,2025-03-31 00:00:00,289817000.0,MOREPENLAB.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,11593072000.0,MOREPENLAB.NS
EBITDA,2025-03-31 00:00:00,1924340000.0,MOREPENLAB.NS
EBIT,2025-03-31 00:00:00,1634523000.0,MOREPENLAB.NS
Net Interest Income,2025-03-31 00:00:00,-83429000.0,MOREPENLAB.NS
Interest Expense,2025-03-31 00:00:00,83429000.0,MOREPENLAB.NS
Interest Income,2025-03-31 00:00:00,,MOREPENLAB.NS
Normalized Income,2025-03-31 00:00:00,1180204000.0,MOREPENLAB.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,1180204000.0,MOREPENLAB.NS
Total Expenses,2025-03-31 00:00:00,16664872000.0,MOREPENLAB.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,MOREPENLAB.NS
Diluted Average Shares,2025-03-31 00:00:00,,MOREPENLAB.NS
Basic Average Shares,2025-03-31 00:00:00,,MOREPENLAB.NS
Diluted EPS,2025-03-31 00:00:00,,MOREPENLAB.NS
Basic EPS,2025-03-31 00:00:00,,MOREPENLAB.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,1180204000.0,MOREPENLAB.NS
Net Income Common Stockholders,2025-03-31 00:00:00,1180204000.0,MOREPENLAB.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,MOREPENLAB.NS
Net Income,2025-03-31 00:00:00,1180204000.0,MOREPENLAB.NS
Minority Interests,2025-03-31 00:00:00,50000.0,MOREPENLAB.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,1180154000.0,MOREPENLAB.NS
Net Income Continuous Operations,2025-03-31 00:00:00,1180154000.0,MOREPENLAB.NS
Tax Provision,2025-03-31 00:00:00,370940000.0,MOREPENLAB.NS
Pretax Income,2025-03-31 00:00:00,1551094000.0,MOREPENLAB.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,183637000.0,MOREPENLAB.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-83429000.0,MOREPENLAB.NS
Total Other Finance Cost,2025-03-31 00:00:00,,MOREPENLAB.NS
Interest Expense Non Operating,2025-03-31 00:00:00,83429000.0,MOREPENLAB.NS
Interest Income Non Operating,2025-03-31 00:00:00,,MOREPENLAB.NS
Operating Income,2025-03-31 00:00:00,1450886000.0,MOREPENLAB.NS
Operating Expense,2025-03-31 00:00:00,5071800000.0,MOREPENLAB.NS
Other Operating Expenses,2025-03-31 00:00:00,1892981000.0,MOREPENLAB.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,289817000.0,MOREPENLAB.NS
Depreciation Income Statement,2025-03-31 00:00:00,289817000.0,MOREPENLAB.NS
Research And Development,2025-03-31 00:00:00,,MOREPENLAB.NS
Selling General And Administration,2025-03-31 00:00:00,799863000.0,MOREPENLAB.NS
Selling And Marketing Expense,2025-03-31 00:00:00,799863000.0,MOREPENLAB.NS
General And Administrative Expense,2025-03-31 00:00:00,,MOREPENLAB.NS
Rent And Landing Fees,2025-03-31 00:00:00,,MOREPENLAB.NS
Gross Profit,2025-03-31 00:00:00,6522686000.0,MOREPENLAB.NS
Cost Of Revenue,2025-03-31 00:00:00,11593072000.0,MOREPENLAB.NS
Total Revenue,2025-03-31 00:00:00,18115758000.0,MOREPENLAB.NS
Operating Revenue,2025-03-31 00:00:00,18115758000.0,MOREPENLAB.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,MOREPENLAB.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.286491,MOREPENLAB.NS
Normalized EBITDA,2024-03-31 00:00:00,1725954000.0,MOREPENLAB.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,961599000.0,MOREPENLAB.NS
Reconciled Depreciation,2024-03-31 00:00:00,334695000.0,MOREPENLAB.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,10624249000.0,MOREPENLAB.NS
EBITDA,2024-03-31 00:00:00,1725954000.0,MOREPENLAB.NS
EBIT,2024-03-31 00:00:00,1391259000.0,MOREPENLAB.NS
Net Interest Income,2024-03-31 00:00:00,-37102000.0,MOREPENLAB.NS
Interest Expense,2024-03-31 00:00:00,37102000.0,MOREPENLAB.NS
Interest Income,2024-03-31 00:00:00,25041000.0,MOREPENLAB.NS
Normalized Income,2024-03-31 00:00:00,961599000.0,MOREPENLAB.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,961599000.0,MOREPENLAB.NS
Total Expenses,2024-03-31 00:00:00,15652774000.0,MOREPENLAB.NS
Rent Expense Supplemental,2024-03-31 00:00:00,120812000.0,MOREPENLAB.NS
Diluted Average Shares,2024-03-31 00:00:00,511488830.0,MOREPENLAB.NS
Basic Average Shares,2024-03-31 00:00:00,511488830.0,MOREPENLAB.NS
Diluted EPS,2024-03-31 00:00:00,1.88,MOREPENLAB.NS
Basic EPS,2024-03-31 00:00:00,1.88,MOREPENLAB.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,961599000.0,MOREPENLAB.NS
Net Income Common Stockholders,2024-03-31 00:00:00,961599000.0,MOREPENLAB.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,MOREPENLAB.NS
Net Income,2024-03-31 00:00:00,961599000.0,MOREPENLAB.NS
Minority Interests,2024-03-31 00:00:00,-4604000.0,MOREPENLAB.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,966203000.0,MOREPENLAB.NS
Net Income Continuous Operations,2024-03-31 00:00:00,966203000.0,MOREPENLAB.NS
Tax Provision,2024-03-31 00:00:00,387954000.0,MOREPENLAB.NS
Pretax Income,2024-03-31 00:00:00,1354157000.0,MOREPENLAB.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,139708000.0,MOREPENLAB.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-37102000.0,MOREPENLAB.NS
Total Other Finance Cost,2024-03-31 00:00:00,,MOREPENLAB.NS
Interest Expense Non Operating,2024-03-31 00:00:00,37102000.0,MOREPENLAB.NS
Interest Income Non Operating,2024-03-31 00:00:00,25041000.0,MOREPENLAB.NS
Operating Income,2024-03-31 00:00:00,1251551000.0,MOREPENLAB.NS
Operating Expense,2024-03-31 00:00:00,5028525000.0,MOREPENLAB.NS
Other Operating Expenses,2024-03-31 00:00:00,1779386000.0,MOREPENLAB.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,334695000.0,MOREPENLAB.NS
Depreciation Income Statement,2024-03-31 00:00:00,334695000.0,MOREPENLAB.NS
Research And Development,2024-03-31 00:00:00,51983000.0,MOREPENLAB.NS
Selling General And Administration,2024-03-31 00:00:00,1099789000.0,MOREPENLAB.NS
Selling And Marketing Expense,2024-03-31 00:00:00,1099789000.0,MOREPENLAB.NS
General And Administrative Expense,2024-03-31 00:00:00,173357000.0,MOREPENLAB.NS
Rent And Landing Fees,2024-03-31 00:00:00,120812000.0,MOREPENLAB.NS
Gross Profit,2024-03-31 00:00:00,6280076000.0,MOREPENLAB.NS
Cost Of Revenue,2024-03-31 00:00:00,10624249000.0,MOREPENLAB.NS
Total Revenue,2024-03-31 00:00:00,16904325000.0,MOREPENLAB.NS
Operating Revenue,2024-03-31 00:00:00,16904325000.0,MOREPENLAB.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,MOREPENLAB.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.306335,MOREPENLAB.NS
Normalized EBITDA,2023-03-31 00:00:00,856665000.0,MOREPENLAB.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,386752000.0,MOREPENLAB.NS
Reconciled Depreciation,2023-03-31 00:00:00,279304000.0,MOREPENLAB.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,9703728000.0,MOREPENLAB.NS
EBITDA,2023-03-31 00:00:00,856665000.0,MOREPENLAB.NS
EBIT,2023-03-31 00:00:00,577361000.0,MOREPENLAB.NS
Net Interest Income,2023-03-31 00:00:00,-3234000.0,MOREPENLAB.NS
Interest Expense,2023-03-31 00:00:00,19808000.0,MOREPENLAB.NS
Interest Income,2023-03-31 00:00:00,16574000.0,MOREPENLAB.NS
Normalized Income,2023-03-31 00:00:00,386752000.0,MOREPENLAB.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,386752000.0,MOREPENLAB.NS
Total Expenses,2023-03-31 00:00:00,13623523000.0,MOREPENLAB.NS
Rent Expense Supplemental,2023-03-31 00:00:00,107401000.0,MOREPENLAB.NS
Diluted Average Shares,2023-03-31 00:00:00,502206570.0,MOREPENLAB.NS
Basic Average Shares,2023-03-31 00:00:00,502206570.0,MOREPENLAB.NS
Diluted EPS,2023-03-31 00:00:00,0.77,MOREPENLAB.NS
Basic EPS,2023-03-31 00:00:00,0.77,MOREPENLAB.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,386752000.0,MOREPENLAB.NS
Net Income Common Stockholders,2023-03-31 00:00:00,386752000.0,MOREPENLAB.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,MOREPENLAB.NS
Net Income,2023-03-31 00:00:00,386752000.0,MOREPENLAB.NS
Minority Interests,2023-03-31 00:00:00,-3000.0,MOREPENLAB.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,386755000.0,MOREPENLAB.NS
Net Income Continuous Operations,2023-03-31 00:00:00,386755000.0,MOREPENLAB.NS
Tax Provision,2023-03-31 00:00:00,170798000.0,MOREPENLAB.NS
Pretax Income,2023-03-31 00:00:00,557553000.0,MOREPENLAB.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,44760000.0,MOREPENLAB.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-3234000.0,MOREPENLAB.NS
Total Other Finance Cost,2023-03-31 00:00:00,,MOREPENLAB.NS
Interest Expense Non Operating,2023-03-31 00:00:00,19808000.0,MOREPENLAB.NS
Interest Income Non Operating,2023-03-31 00:00:00,16574000.0,MOREPENLAB.NS
Operating Income,2023-03-31 00:00:00,516025000.0,MOREPENLAB.NS
Operating Expense,2023-03-31 00:00:00,3919795000.0,MOREPENLAB.NS
Other Operating Expenses,2023-03-31 00:00:00,919589000.0,MOREPENLAB.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,279304000.0,MOREPENLAB.NS
Depreciation Income Statement,2023-03-31 00:00:00,279304000.0,MOREPENLAB.NS
Research And Development,2023-03-31 00:00:00,30689000.0,MOREPENLAB.NS
Selling General And Administration,2023-03-31 00:00:00,1071758000.0,MOREPENLAB.NS
Selling And Marketing Expense,2023-03-31 00:00:00,930136000.0,MOREPENLAB.NS
General And Administrative Expense,2023-03-31 00:00:00,141622000.0,MOREPENLAB.NS
Rent And Landing Fees,2023-03-31 00:00:00,107401000.0,MOREPENLAB.NS
Gross Profit,2023-03-31 00:00:00,4435820000.0,MOREPENLAB.NS
Cost Of Revenue,2023-03-31 00:00:00,9703728000.0,MOREPENLAB.NS
Total Revenue,2023-03-31 00:00:00,14139548000.0,MOREPENLAB.NS
Operating Revenue,2023-03-31 00:00:00,14139548000.0,MOREPENLAB.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,0.0,MOREPENLAB.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.197481,MOREPENLAB.NS
Normalized EBITDA,2022-03-31 00:00:00,1567712000.0,MOREPENLAB.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,1016827000.0,MOREPENLAB.NS
Reconciled Depreciation,2022-03-31 00:00:00,276425000.0,MOREPENLAB.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,10609373000.0,MOREPENLAB.NS
EBITDA,2022-03-31 00:00:00,1567712000.0,MOREPENLAB.NS
EBIT,2022-03-31 00:00:00,1291287000.0,MOREPENLAB.NS
Net Interest Income,2022-03-31 00:00:00,-10963000.0,MOREPENLAB.NS
Interest Expense,2022-03-31 00:00:00,24261000.0,MOREPENLAB.NS
Interest Income,2022-03-31 00:00:00,13298000.0,MOREPENLAB.NS
Normalized Income,2022-03-31 00:00:00,1016827000.0,MOREPENLAB.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,1016827000.0,MOREPENLAB.NS
Total Expenses,2022-03-31 00:00:00,14325353000.0,MOREPENLAB.NS
Rent Expense Supplemental,2022-03-31 00:00:00,81823000.0,MOREPENLAB.NS
Diluted Average Shares,2022-03-31 00:00:00,519826203.0,MOREPENLAB.NS
Basic Average Shares,2022-03-31 00:00:00,449979628.0,MOREPENLAB.NS
Diluted EPS,2022-03-31 00:00:00,1.96,MOREPENLAB.NS
Basic EPS,2022-03-31 00:00:00,2.26,MOREPENLAB.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,1016827000.0,MOREPENLAB.NS
Net Income Common Stockholders,2022-03-31 00:00:00,1016827000.0,MOREPENLAB.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,MOREPENLAB.NS
Net Income,2022-03-31 00:00:00,1016827000.0,MOREPENLAB.NS
Minority Interests,2022-03-31 00:00:00,14000.0,MOREPENLAB.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,1016813000.0,MOREPENLAB.NS
Net Income Continuous Operations,2022-03-31 00:00:00,1016813000.0,MOREPENLAB.NS
Tax Provision,2022-03-31 00:00:00,250213000.0,MOREPENLAB.NS
Pretax Income,2022-03-31 00:00:00,1267026000.0,MOREPENLAB.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,89774000.0,MOREPENLAB.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-10963000.0,MOREPENLAB.NS
Total Other Finance Cost,2022-03-31 00:00:00,,MOREPENLAB.NS
Interest Expense Non Operating,2022-03-31 00:00:00,24261000.0,MOREPENLAB.NS
Interest Income Non Operating,2022-03-31 00:00:00,13298000.0,MOREPENLAB.NS
Operating Income,2022-03-31 00:00:00,1090298000.0,MOREPENLAB.NS
Operating Expense,2022-03-31 00:00:00,3715980000.0,MOREPENLAB.NS
Other Operating Expenses,2022-03-31 00:00:00,1060154000.0,MOREPENLAB.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,276425000.0,MOREPENLAB.NS
Depreciation Income Statement,2022-03-31 00:00:00,276425000.0,MOREPENLAB.NS
Research And Development,2022-03-31 00:00:00,30082000.0,MOREPENLAB.NS
Selling General And Administration,2022-03-31 00:00:00,677649000.0,MOREPENLAB.NS
Selling And Marketing Expense,2022-03-31 00:00:00,535799000.0,MOREPENLAB.NS
General And Administrative Expense,2022-03-31 00:00:00,141850000.0,MOREPENLAB.NS
Rent And Landing Fees,2022-03-31 00:00:00,81823000.0,MOREPENLAB.NS
Gross Profit,2022-03-31 00:00:00,4806278000.0,MOREPENLAB.NS
Cost Of Revenue,2022-03-31 00:00:00,10609373000.0,MOREPENLAB.NS
Total Revenue,2022-03-31 00:00:00,15415651000.0,MOREPENLAB.NS
Operating Revenue,2022-03-31 00:00:00,15415651000.0,MOREPENLAB.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,MOREPENLAB.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,MOREPENLAB.NS
Normalized EBITDA,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,MOREPENLAB.NS
Reconciled Depreciation,2021-03-31 00:00:00,,MOREPENLAB.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,MOREPENLAB.NS
EBITDA,2021-03-31 00:00:00,,MOREPENLAB.NS
EBIT,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Interest Income,2021-03-31 00:00:00,,MOREPENLAB.NS
Interest Expense,2021-03-31 00:00:00,,MOREPENLAB.NS
Interest Income,2021-03-31 00:00:00,21343000.0,MOREPENLAB.NS
Normalized Income,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,MOREPENLAB.NS
Total Expenses,2021-03-31 00:00:00,,MOREPENLAB.NS
Rent Expense Supplemental,2021-03-31 00:00:00,51400000.0,MOREPENLAB.NS
Diluted Average Shares,2021-03-31 00:00:00,451072778.0,MOREPENLAB.NS
Basic Average Shares,2021-03-31 00:00:00,449826203.0,MOREPENLAB.NS
Diluted EPS,2021-03-31 00:00:00,2.15,MOREPENLAB.NS
Basic EPS,2021-03-31 00:00:00,2.16,MOREPENLAB.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,MOREPENLAB.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Income,2021-03-31 00:00:00,,MOREPENLAB.NS
Minority Interests,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,MOREPENLAB.NS
Tax Provision,2021-03-31 00:00:00,,MOREPENLAB.NS
Pretax Income,2021-03-31 00:00:00,,MOREPENLAB.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,MOREPENLAB.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,MOREPENLAB.NS
Total Other Finance Cost,2021-03-31 00:00:00,4892000.0,MOREPENLAB.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,MOREPENLAB.NS
Interest Income Non Operating,2021-03-31 00:00:00,21343000.0,MOREPENLAB.NS
Operating Income,2021-03-31 00:00:00,,MOREPENLAB.NS
Operating Expense,2021-03-31 00:00:00,,MOREPENLAB.NS
Other Operating Expenses,2021-03-31 00:00:00,,MOREPENLAB.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,MOREPENLAB.NS
Depreciation Income Statement,2021-03-31 00:00:00,,MOREPENLAB.NS
Research And Development,2021-03-31 00:00:00,56461000.0,MOREPENLAB.NS
Selling General And Administration,2021-03-31 00:00:00,,MOREPENLAB.NS
Selling And Marketing Expense,2021-03-31 00:00:00,,MOREPENLAB.NS
General And Administrative Expense,2021-03-31 00:00:00,121705000.0,MOREPENLAB.NS
Rent And Landing Fees,2021-03-31 00:00:00,51400000.0,MOREPENLAB.NS
Gross Profit,2021-03-31 00:00:00,,MOREPENLAB.NS
Cost Of Revenue,2021-03-31 00:00:00,,MOREPENLAB.NS
Total Revenue,2021-03-31 00:00:00,,MOREPENLAB.NS
Operating Revenue,2021-03-31 00:00:00,,MOREPENLAB.NS
